Hou Y, Nie Z, Jiang Q, Velychko S, Heising S, Bedzhov I
Elife. 2025; 13.
PMID: 40014376
PMC: 11867617.
DOI: 10.7554/eLife.100735.
Yang J
Cells. 2025; 14(3).
PMID: 39936946
PMC: 11817359.
DOI: 10.3390/cells14030154.
Mirizio G, Sampson S, Iwafuchi M
Regen Ther. 2025; 28():246-252.
PMID: 39834592
PMC: 11745816.
DOI: 10.1016/j.reth.2024.12.014.
ODwyer M, Azagury M, Furlong K, Alsheikh A, Hall-Ponsele E, Pinto H
Nature. 2024; 638(8049):251-260.
PMID: 39695228
PMC: 11798873.
DOI: 10.1038/s41586-024-08333-9.
Karamveer , Uzun Y
Bioinform Biol Insights. 2024; 18:11779322241287120.
PMID: 39502448
PMC: 11536393.
DOI: 10.1177/11779322241287120.
Neural crest precursors from the skin are the primary source of directly reprogrammed neurons.
Belair-Hickey J, Fahmy A, Zhang W, Sajid R, Coles B, Salter M
Stem Cell Reports. 2024; 19(11):1620-1634.
PMID: 39486406
PMC: 11589197.
DOI: 10.1016/j.stemcr.2024.10.003.
Lung Immune Cell Niches and the Discovery of New Cell Subtypes.
Shan Q, Qiu J, Dong Z, Xu X, Zhang S, Ma J
Adv Sci (Weinh). 2024; 11(45):e2405490.
PMID: 39401416
PMC: 11615829.
DOI: 10.1002/advs.202405490.
Manipulating cell fate through reprogramming: approaches and applications.
Yagi M, Horng J, Hochedlinger K
Development. 2024; 151(19).
PMID: 39348466
PMC: 11463964.
DOI: 10.1242/dev.203090.
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs).
Manganelli M, Mazzoldi E, Ferraro R, Pinelli M, Parigi M, Aghel S
Stem Cell Rev Rep. 2024; 20(8):2303-2317.
PMID: 39168923
PMC: 11554879.
DOI: 10.1007/s12015-024-10776-6.
Advances in induced pluripotent stem cell-derived cardiac myocytes: technological breakthroughs, key discoveries and new applications.
Clancy C, Santana L
J Physiol. 2024; 602(16):3871-3892.
PMID: 39032073
PMC: 11326976.
DOI: 10.1113/JP282562.
Mechanisms of Embryonic Stem Cell Pluripotency Maintenance and Their Application in Livestock and Poultry Breeding.
Wang Z, Gong W, Yao Z, Jin K, Niu Y, Li B
Animals (Basel). 2024; 14(12).
PMID: 38929361
PMC: 11201147.
DOI: 10.3390/ani14121742.
Hypoxia Increases the Efficiencies of Cellular Reprogramming and Oncogenic Transformation in Human Blood Cell Subpopulations In Vitro and In Vivo.
Moratilla A, Martin D, Cadenas-Martin M, Stokking M, Quesada M, Arnalich F
Cells. 2024; 13(11.
PMID: 38891103
PMC: 11172288.
DOI: 10.3390/cells13110971.
A chemical approach facilitates CRISPRa-only human iPSC generation and minimizes the number of targeted loci required.
Abujarour R, Dinella J, Pribadi M, Fong L, Denholtz M, Gutierrez A
Future Sci OA. 2024; 10(1):FSO964.
PMID: 38817352
PMC: 11137772.
DOI: 10.2144/fsoa-2023-0257.
The occurrence and development of induced pluripotent stem cells.
Chen Y, Li M, Wu Y
Front Genet. 2024; 15:1389558.
PMID: 38699229
PMC: 11063328.
DOI: 10.3389/fgene.2024.1389558.
Contributions of transcriptional noise to leukaemia evolution: KAT2A as a case-study.
Pina C
Philos Trans R Soc Lond B Biol Sci. 2024; 379(1900):20230052.
PMID: 38432321
PMC: 10909511.
DOI: 10.1098/rstb.2023.0052.
Retrospective identification of cell-intrinsic factors that mark pluripotency potential in rare somatic cells.
Jain N, Goyal Y, Dunagin M, Cote C, Mellis I, Emert B
Cell Syst. 2024; 15(2):109-133.e10.
PMID: 38335955
PMC: 10940218.
DOI: 10.1016/j.cels.2024.01.001.
Initiation phase cellular reprogramming ameliorates DNA damage in the ERCC1 mouse model of premature aging.
Paine P, Rechsteiner C, Morandini F, Desdin-Mico G, Mrabti C, Parras A
Front Aging. 2024; 4():1323194.
PMID: 38322248
PMC: 10844398.
DOI: 10.3389/fragi.2023.1323194.
Metabolic control of induced pluripotency.
Sinenko S, Tomilin A
Front Cell Dev Biol. 2024; 11:1328522.
PMID: 38274274
PMC: 10808704.
DOI: 10.3389/fcell.2023.1328522.
The thyroid hormone enhances mouse embryonic fibroblasts reprogramming to pluripotent stem cells: role of the nuclear receptor corepressor 1.
Contreras-Jurado C, Montero-Pedrazuela A, Perez R, Alemany S, Fraga M, Aranda A
Front Endocrinol (Lausanne). 2023; 14:1235614.
PMID: 38107517
PMC: 10722291.
DOI: 10.3389/fendo.2023.1235614.
Synthetic genetic circuits to uncover the OCT4 trajectories of successful reprogramming of human fibroblasts.
Ilia K, Shakiba N, Bingham T, Jones R, Kaminski M, Aravera E
Sci Adv. 2023; 9(48):eadg8495.
PMID: 38019912
PMC: 10686568.
DOI: 10.1126/sciadv.adg8495.